Bisphosphonates induce apoptosis in human breast cancer cell lines SG Senaratne, G Pirianov, JL Mansi, TR Arnett, KW Colston British journal of cancer 82 (8), 1459-1468, 2000 | 587 | 2000 |
Effect of pH on Bone Resorption by Rat Osteoclasts in Vitro TR ARNETT, DW DEMPSTER Endocrinology 119 (1), 119-124, 1986 | 422 | 1986 |
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro GJ Spencer, JC Utting, SL Etheridge, TR Arnett, PG Genever Journal of cell science 119 (7), 1283-1296, 2006 | 421 | 2006 |
Hypoxia is a major stimulator of osteoclast formation and bone resorption TR Arnett, DC Gibbons, JC Utting, IR Orriss, A Hoebertz, M Rosendaal, ... Journal of cellular physiology 196 (1), 2-8, 2003 | 402 | 2003 |
Extracellular pH regulates bone cell function TR Arnett The Journal of nutrition 138 (2), 415S-418S, 2008 | 397 | 2008 |
Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts JC Utting, SP Robins, A Brandao-Burch, IR Orriss, J Behar, TR Arnett Experimental cell research 312 (10), 1693-1702, 2006 | 360 | 2006 |
The key role of the blood supply to bone M Marenzana, TR Arnett Bone research 1 (1), 203-215, 2013 | 354 | 2013 |
Arg Gly Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts MA Horton, ML Taylor, TR Arnett, MH Helfrich Experimental cell research 195 (2), 368-375, 1991 | 308 | 1991 |
Acidosis Inhibits Bone Formation by Osteoblasts In Vitro by Preventing Mineralization A Brandao-Burch, JC Utting, IR Orriss, TR Arnett Calcified tissue international 77, 167-174, 2005 | 307 | 2005 |
Acidosis, hypoxia and bone TR Arnett Archives of biochemistry and biophysics 503 (1), 103-109, 2010 | 303 | 2010 |
Regulation of bone cell function by acid-base balance T Arnett PROCEEDINGS OF THE NUTRITION SOCIETY 62 (2), 495-500, 2003 | 276 | 2003 |
A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins TR ARNETT, DW DEMPSTER Endocrinology 120 (2), 602-608, 1987 | 222 | 1987 |
AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass M Shah, B Kola, A Bataveljic, TR Arnett, B Viollet, L Saxon, M Korbonits, ... Bone 47 (2), 309-319, 2010 | 210 | 2010 |
Modulation of the resorptive activity of rat osteoclasts by small changes in extracellular pH near the physiological range TR Arnett, M Spowage Bone 18 (3), 277-279, 1996 | 195 | 1996 |
Regulation of bone resorption and formation by purines and pyrimidines A Hoebertz, TR Arnett, G Burnstock Trends in Pharmacological Sciences 24 (6), 290-297, 2003 | 173 | 2003 |
Expression of P2 receptors in bone and cultured bone cells A Hoebertz, A Townsend-Nicholson, R Glass, G Burnstock, TR Arnett Bone 27 (4), 503-510, 2000 | 173 | 2000 |
Differences in proximal femur bone density over two centuries B Lees, JC Stevenson, T Molleson, TR Arnett The Lancet 341 (8846), 673-676, 1993 | 168 | 1993 |
Extracellular Nucleotides Block Bone Mineralization in Vitro: Evidence for Dual Inhibitory Mechanisms Involving Both P2Y2 Receptors and Pyrophosphate IR Orriss, JC Utting, A Brandao-Burch, K Colston, BR Grubb, G Burnstock, ... Endocrinology 148 (9), 4208-4216, 2007 | 164 | 2007 |
Pyrophosphate: a key inhibitor of mineralisation IR Orriss, TR Arnett, RGG Russell Current opinion in pharmacology 28, 57-68, 2016 | 162 | 2016 |
Inhibiting activin‐A signaling stimulates bone formation and prevents cancer‐induced bone destruction in vivo AD Chantry, D Heath, AW Mulivor, S Pearsall, M Baud'huin, L Coulton, ... Journal of Bone and Mineral Research 25 (12), 2633-2646, 2010 | 162 | 2010 |